Patents
Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
07/2012
07/18/2012CN102596951A Heterocyclic sulfonamide derivatives useful as mek inhibitors
07/18/2012CN102596950A Deuterated compounds for electronic applications
07/18/2012CN102584852A Qiaonan mycin serving as fungus metabolism product and preparation method and application thereof
07/18/2012CN102584836A Porphyrin cage compound, and preparation method and application thereof
07/18/2012CN102584799A Aromatic nitrogenous six-membered ring compounds
07/18/2012CN102584736A Method for catalyzing and oxidizing hydroxamic acids
07/18/2012CN102020651B 6-aryl amino pyridone formamide MEK (methyl ethyl ketone) inhibitor
07/18/2012CN101460457B Total synthesis of salinosporamide a and analogs thereof
07/18/2012CN101407524B Oxazino camptothecin derivative, preparation and use thereof
07/18/2012CN101115761B Prodrugs of 2,4-pyrimidinediamine compounds and their uses
07/18/2012CN101072781B Macrocyclic quinazoline derivatives and their use as mtki
07/17/2012US8222407 Mutilin derivative having heterocyclic aromatic ring carboxylic acid structure in substituent at 14-position
07/17/2012US8222244 Staurosporine derivatives as inhibitors of FLT3 receptor tyrosine kinase activity
07/12/2012WO2012092741A1 Process for synthesis of torisel
07/12/2012WO2012092740A1 Process for preparing torisel
07/12/2012US20120178924 Hexahydrooxazinopterine compounds
07/12/2012US20120178774 Toll-like receptor modulators and uses thereof
07/12/2012US20120178748 Heteroaryl compounds and methods of use thereof
07/12/2012US20120178715 SUBSTITUTED PYRAZOLO[1,5-a]PYRIMIDINE COMPOUNDS AS mTOR INHIBITORS
07/12/2012US20120178714 Phosphorus-containing Compounds & Uses Thereof
07/12/2012US20120177690 Use of rapamycin derivatives in vasculopathies and xenotransplantation
07/11/2012EP2473055A1 Mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
07/11/2012EP2473041A1 Modulators of cell cycle checkpoints and their use in combination with checkpoint kinase inhibitors
07/11/2012CN1900074B Substituted oxazolidinones and their use in the field of blood coagulation
07/11/2012CN102574865A Spirocyclic derivatives as histone deacetylase inhibitors
07/11/2012CN102574854A Macrocyclic integrase inhibitors
07/11/2012CN102574815A Mesoionic pesticides
07/11/2012CN102573994A Novel bicyclic urea compounds
07/11/2012CN102573492A Composition and method for controlling arthropod pests
07/11/2012CN102573491A Composition and method for controlling arthropod pests
07/11/2012CN102573490A Composition and method for controlling arthropod pests
07/11/2012CN102573488A Composition and method for controlling arthropod pests
07/11/2012CN102558197A Preparation method of levofloxacin-N-oxide
07/11/2012CN102558140A Derivatives of 4-piperazin-1-1-yl-4-benzo [b] thiophene suitable for the treatment of cns disorders
07/11/2012CN102557982A Certain chemical entities, compositions, and methods
07/10/2012US8217064 Tetrasubstituted benzenes
07/10/2012US8217034 Chemical compounds
07/10/2012CA2658334C Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
07/10/2012CA2551171C Modulators of peripheral 5-ht receptors
07/05/2012WO2012090177A2 Cannabinoid receptor modulators
07/05/2012WO2012089349A2 Novel polyketide compounds and methods of making same
07/05/2012WO2012024558A3 Light mediated regulation of protein dimerization
07/05/2012WO2011085643A8 Fused pyridine derivatives
07/05/2012US20120172402 Induction of alpha helix conformations in proteins and peptides
07/05/2012US20120172367 Macrocyclic integrase inhibitors
07/05/2012US20120172352 Pyrazoline dione derivatives as nadph oxidase inhibitors
07/05/2012US20120171199 Tricyclic pi3k inhibitor compounds and methods of use
07/04/2012EP2471797A2 17-Desmethylrapamycin and analogues thereof, methods for their production and their use as immunosupressants, anticancer agents, antifungal agents etc.
07/04/2012EP2471792A1 3-(biaryloxy) propionic acid derivative
07/04/2012EP2470546A1 HEXAHYDROOXAZINOPTERINE COMPOUNDS FOR USE AS mTOR INHIBITORS
07/04/2012EP2470545A1 Anhydrate forms of a pyridine derivative
07/04/2012EP2470527A1 Ether benzotriazole derivatives
07/04/2012EP2470513A1 Macrocyclic hopo chelators
07/04/2012EP1689233B1 Bicyclic inhibitors of mek
07/04/2012CN102548973A Mesoionic pesticides
07/04/2012CN102532163A Macrocyclic 4-amino-quinazoline derivatives and their use as MTKI
07/04/2012CN102532162A 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles
07/04/2012CN102127087B Quinazoline derivatives
07/04/2012CN102079749B Method for producing rifampicin raw material medicines with densities of less than or equal to 0.3g/ml and more than or equal to 0.8g/ml
07/04/2012CN101768167B Method for synthesizing piperazine of levofloxacin
07/04/2012CN101712685B Refining method of crude tacrolimus
07/04/2012CN101568336B Macrocyclic peptides as hepatitis c virus inhibitors
07/04/2012CN101550143B Industrial compounding method of mule (benzo (e) (1,3) oxazine-2, 4'-piperidine)-4(3H)-ketonic
07/03/2012US8211921 Heterocyclic inhibitors of MEK and methods of use
07/03/2012US8211889 Prodrugs of 2,4-pyrimidinediamine compounds and their uses
07/03/2012US8211338 Photochromic compounds
07/03/2012CA2568356C Bicyclic heterocycles as hiv integrase inhibitors
06/2012
06/28/2012WO2012086848A1 Fused heterocyclic compound and use for pest control thereof
06/28/2012US20120165547 Supports for oligomer synthesis
06/28/2012US20120165519 Fused Bicyclic Derivatives of 2,4-Diaminopyrimidine as ALK and c-MET Inhibitors
06/28/2012US20120165331 Di/tri-aza-spiro-C9-C11alkanes
06/28/2012US20120165321 Quinoline derivatives as pi3 kinase inhibitors
06/28/2012US20120165312 Fused heterocyclic compound and use thereof
06/28/2012US20120165298 Sulfonamide compounds
06/28/2012CA2822919A1 Fused heterocyclic compound and use for pest control thereof
06/27/2012EP2468752A1 Thiazolopyridine derivatives as sirtuin-modulators
06/27/2012CN102516260A Method for preparing picrinine
06/27/2012CN102516155A 2-alkoxy-4-halo-6-alkylphenyl-substituted (hetero)cyclic ketoenols
06/27/2012CN102070650B Preparation method for levofloxacin-N-oxide
06/27/2012CN101516860B Benzoxazoles and oxazolopyridines being useful as FANUS kinases inhibitors
06/27/2012CN101103000B Carbazole, carboline, and indole derivatives useful in the inhibition of VEGF production
06/26/2012US8207188 Treatment of diseases modulated by a H4 receptor agonist
06/26/2012CA2511970C Urea derivatives useful in the treatment of heart failure
06/21/2012WO2012082997A1 Tricyclic pi3k inhibitor compounds and methods of use
06/21/2012WO2012082633A1 Novel 1,2- bis-sulfonamide derivatives as chemokine receptor modulators
06/21/2012WO2012080457A1 Bicyclic ring system substituted sulfonamide functionalised phenols as medicaments
06/21/2012WO2012080456A1 Bicyclic ring system substituted amide functionalised phenols as medicaments
06/21/2012US20120157471 Benzimidazole derivatives
06/21/2012US20120157450 Anhydrate Forms Of A Pyridine Derivative
06/21/2012US20120157448 Compounds for treating neurodegenerative diseases
06/21/2012US20120157440 Novel fused pyridine compounds as casein kinase inhibitors
06/21/2012US20120157434 Antimicrobial heterocyclic compounds for treatment of bacterial infections
06/21/2012US20120157428 Bromodomain inhibitors and uses thereof
06/21/2012US20120157383 Neprilysin inhibitors
06/21/2012CA2822044A1 Novel 1,2- bis-sulfonamide derivatives as chemokine receptor modulators
06/21/2012CA2820078A1 Tricyclic pi3k inhibitor compounds and methods of use
06/20/2012EP2465580A1 Polycyclic carbamoylpyridone derivatives having hiv integrase inhibitory activity
06/20/2012EP2464651A1 New macrolides and their use
06/20/2012CN102510867A Glycoside derivative and uses thereof
06/20/2012CN102503955A Phthalimide nitrogen heteroaryl amide heteroaryl 15-crown ether and synthesis method thereof
1 ... 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 ... 220